Your browser doesn't support javascript.
loading
XPO1/CRM1 Inhibition Causes Antitumor Effects by Mitochondrial Accumulation of eIF5A.
Miyake, Takahito; Pradeep, Sunila; Wu, Sherry Y; Rupaimoole, Rajesha; Zand, Behrouz; Wen, Yunfei; Gharpure, Kshipra M; Nagaraja, Archana S; Hu, Wei; Cho, Min Soon; Dalton, Heather J; Previs, Rebecca A; Taylor, Morgan L; Hisamatsu, Takeshi; Kang, Yu; Liu, Tao; Shacham, Sharon; McCauley, Dilara; Hawke, David H; Wiktorowicz, John E; Coleman, Robert L; Sood, Anil K.
Afiliação
  • Miyake T; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Pradeep S; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wu SY; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Rupaimoole R; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Zand B; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wen Y; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Gharpure KM; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Nagaraja AS; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Hu W; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Cho MS; Department of Benign Hematology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Dalton HJ; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Previs RA; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Taylor ML; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Hisamatsu T; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Kang Y; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Liu T; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Shacham S; Karyopharm Therapeutics Inc., Natick, Massachusetts.
  • McCauley D; Karyopharm Therapeutics Inc., Natick, Massachusetts.
  • Hawke DH; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wiktorowicz JE; Department of Biochemistry and Molecular Biology, NHLBI Proteomics Center, The University of Texas Medical Branch, Galveston, Texas.
  • Coleman RL; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Sood AK; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Center for RNA Interference and Non-coding RNA, The University of Texas MD
Clin Cancer Res ; 21(14): 3286-97, 2015 Jul 15.
Article em En | MEDLINE | ID: mdl-25878333
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Fatores de Iniciação de Peptídeos / Proteínas de Ligação a RNA / Receptores Citoplasmáticos e Nucleares / Carioferinas / Neoplasias Mamárias Experimentais / Mitocôndrias / Antineoplásicos Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Fatores de Iniciação de Peptídeos / Proteínas de Ligação a RNA / Receptores Citoplasmáticos e Nucleares / Carioferinas / Neoplasias Mamárias Experimentais / Mitocôndrias / Antineoplásicos Idioma: En Ano de publicação: 2015 Tipo de documento: Article